SEC Form 4 · accession 0001179110-15-008618
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
May 26, 2015
Accepted (ET)
May 27, 2015 · 11:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2015 | S | 65 | $19.80 | D | 110,569 | D | |
| Common Stock | May 26, 2015 | S | 69 | $19.80 | D | 110,500 | D | |
| Common Stock | May 26, 2015 | S | 120 | $19.80 | D | 110,380 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2013.